Audrey Duval Derveloy Appointed Global Head of Corporate Affairs at Sanofi
Audrey Duval Derveloy, a seasoned leader in the healthcare industry and current President of Sanofi France, has been appointed Executive Vice President and Global Head of Corporate Affairs at Sanofi. She will join Sanofi’s Executive Committee, reporting directly to CEO Paul Hudson, and will be based in Paris starting July 1, 2024.
In her new role, Audrey will oversee Sanofi’s global stakeholder engagement, corporate social responsibility strategy, the not-for-profit Global Health Unit, and Sanofi’s philanthropic arm, Foundation S. She will also retain her role as President of Sanofi France, continuing to support and coordinate Sanofi’s representation to its various external stakeholders in the country.
Paul Hudson, Chief Executive Officer, Sanofi: “I am delighted to welcome Audrey to our Executive Committee. Her leadership over the past two years has been crucial in advancing our company’s modernization in France. She has supported our strategic priorities and helped highlight Sanofi as a leading healthcare company in our home market. Her recent experience, business acumen, and ability to inspire and motivate teams will be essential in driving our global external engagement strategy and achieving our ambition to become a science-driven company transforming medicine for patients worldwide.”
Audrey joined Sanofi from Novartis in September 2022 as President of Sanofi France. A physician by training, she began her career in public hospitals in Paris, then worked as a researcher at the Pasteur Research Center of Hong Kong University and as a scientific expert at Salusmed in Hong Kong. She later joined Pfizer in France, working in medical affairs for Endocrinology, Transplant, and Rheumatology. Audrey then moved to Novartis in France, where she advanced to become Business Franchise Head for Ophthalmology and later, in 2020, Country President for Novartis operations in Ireland. Audrey holds a Medical Doctorate from the Paris Faculté de Médécine Cochin and a Bachelor of Science in Medical Biology.
Audrey Duval Derveloy, Executive Vice-President, Global Head of Corporate Affairs, Sanofi: “For the past two years, I have witnessed the unwavering commitment of our employees in France to serving patients worldwide. Behind each success, from the launch of Beyfortus against RSV to the environmental transition of our industrial sites and the mobilization of thousands of employees for our partnership with Paris 2024, the Corporate Affairs teams have been instrumental. With these successes in mind, I take on these new responsibilities as we continue to modernize Sanofi and strive to become a leader in immunology.
